CNR1 and colorectal cancer: Consistently, CpG methylation of rat Cnr1 promoter, miR23a and miR-301a, previously shown to be involved in the pathogenesis of colorectal cancer [62] and predicted to target CB1 mRNA, were reduced after administration of EVOO down to ~50% of controls [46].